Ebastine Sandoz 10 mg orodisp. tabl.

Country: Belġju

Lingwa: Ingliż

Sors: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ixtrih issa

Ingredjent attiv:

Ebastine 10 mg

Disponibbli minn:

Sandoz SA-NV

Kodiċi ATC:

R06AX22

INN (Isem Internazzjonali):

Ebastine

Dożaġġ:

10 mg

Għamla farmaċewtika:

Orodispersible tablet

Kompożizzjoni:

Ebastine 10 mg

Rotta amministrattiva:

Oral use

Żona terapewtika:

Ebastine

Sommarju tal-prodott:

CTI code: 446471-07 - Pack size: 98 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 446471-08 - Pack size: 100 - Commercialisation status: YES - FMD code: 07613421001407 - CNK code: 3121209 - Delivery mode: Medical prescription; CTI code: 446471-05 - Pack size: 50 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 446471-06 - Pack size: 90 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 446471-03 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 446471-04 - Pack size: 40 - Commercialisation status: YES - FMD code: 07613421001414 - CNK code: 3121191 - Delivery mode: Medical prescription; CTI code: 446471-01 - Pack size: 10 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 446471-02 - Pack size: 20 - Commercialisation status: NO - Delivery mode: Medical prescription

L-istatus ta 'awtorizzazzjoni:

Commercialised: Yes

Data ta 'l-awtorizzazzjoni:

2014-01-09

Dokumenti f'lingwi oħra

Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Ġermaniż 01-07-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Franċiż 01-07-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Franċiż 01-07-2022
RMP RMP Franċiż 10-11-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Olandiż 01-07-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Olandiż 01-07-2022
RMP RMP Olandiż 10-11-2022

Fittex twissijiet relatati ma 'dan il-prodott